Product Information
CEPHALEXIN 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7432 per EA under NDC 00093223801. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jan 12, 1989. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093223801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA063024FDA Approved
1/12/1989
TE Code
AB
On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 250 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7432 per EA |
|---|---|
| All-time high | $0.9564 (Jul 10, 2024) |
| All-time low | $0.6858 (Apr 22, 2026) |
| 52-week high | $0.9351 |
| 52-week low | $0.6858 |
| Median price | $0.9201 |
| Average price | $0.8605 |
| Largest weekly change | -19.7% (Dec 17, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cephalexin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cephalexin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEPHALEXIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7432 per EA (NDC 00093223801), effective Sep 30, 2026.
How has the price of CEPHALEXIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 250 MG TABLET has declined 13.1%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG TABLET?
Since Apr 17, 2024, the NADAC for CEPHALEXIN 250 MG TABLET has ranged from a low of $0.6858 (Apr 22, 2026) to a high of $0.9564 (Jul 10, 2024), with a median of $0.9201 per EA.
Are there cheaper alternatives to CEPHALEXIN 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CEPHALEXIN 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEPHALEXIN 250 MG TABLET?
CEPHALEXIN 250 MG TABLET (NDC 00093223801) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.